AbbVie Beats on Q4 Earnings, Stock Down Despite Upbeat '26 View
unknown
📅 Published: 2026-02-04 17:28
📰 Source: Yahoo
📝 Words: 22
📝 Article Content
ABBV beats Q4 earnings and revenue estimates, but shares slip as Rinvoq and oncology sales miss expectations despite strong 2026 EPS guidance.
📄 Summary
ABBV beats Q4 earnings and revenue estimates, but shares slip as Rinvoq and oncology sales miss expectations despite strong 2026 EPS guidance.
Scraping Metadata:
Scraped At:
Unknown
Created At:
2026-02-05 14:08:16
Updated At:
2026-02-05 14:08:16
Scraping Job ID:
N/A
Stock Mentions:
ABBV - AbbVie Inc.
Relevance: N/A
T - AT&T Inc.
Relevance: N/A